MSB vs RHY

ASX Healthcare sector comparison — updated 22 Jul 2026 — Healthcare sector

MSB

MESOBLAST FPO [MSB]

41LOW

RHY

RHYTHM BIO FPO [RHY]

45LOW

Score Breakdown

MSB RHY
Technical
35
55
Catalyst
53
45
Sentiment
50
50
Fundamental
80
34
Momentum
60
46
Risk Gate
40
50

Key Metrics

MSB Metric RHY
$3.1BMarket Cap$30.4M
4.1MAvg Volume (20d)229K
+7.8%Short InterestN/A
$3.31052-Week High$0.280
$1.88052-Week Low$0.052
-4.5%Daily Change-1.2%
$2.320Reference Price$0.085
-18.2%ROE-190.1%
-144.3%Profit MarginN/A

Active Signals

MSB Signals

Above-average volume (1.6x) on a red day — sellers in control
Took a hit — down 10.4% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (9 quarters)
Strong revenue growth (+1527%)
EPS estimates revised upward (+10pts)
Director buying detected (1 transactions)
Elevated short interest (7.8%)

RHY Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.1 quarters)
Revenue in sharp decline (-49%)

Ask Scout AI to compare MSB and RHY in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MSB vs SNT →MSB vs TRU →MSB vs TTX →MSB vs VBS →MVF vs OCC →
MSB Full Analysis → RHY Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).